SANTOS DAVID A (EVP, Chief Commercial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/4/2026ACC: 0000905148-26-000498
Officer· EVP, Chief Commercial Officer
Since Aug 2020
-5.72K
Net shares
Net seller
$205.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.72K
Price / share
$36.01
Trade value
$205.91K
% of position
10.8%
2/2/2026
52.70K→46.99K
Total
Net shares
−5.72K
Net value
-$205.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | F · Tax Withholding | −5.72K | $36.01 | $205.91K | 10.8% | 52.70K | 46.99K |
| Total | −5.72K | -$205.91K | ||||||
Derivative Transactions0
No derivative transactions reported